Studies have demonstrated that the migration and invasion of endometrial cells in the menstrual blood of patients with EM can be significantly influenced by the abnormal activation of the Wnt/β-catenin and the PI3K/AKT signaling pathways (10, 31). This evidence concerns the gene AKT1 and erythema multiforme.